Studies conducted by Lo et al. [70] and Murray et al. [71] ascertained an independent association between a high pre-treatment serum ALB–BIL grade and worse OS in HCC patients treated with stereotactic body radiation therapy (SBRT) and stereotactic ablative radiation therapy (SABR). Here, ALB is linked to hepatocellular carcinoma.